- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 103,240 | 27.09.24 17:35:53 | +0,900 | +0,88% | 0,000 | 0,000 | 101,860 | 102,340 |
|
Regeneron Pharmaceuticals | 881535 | NASDAQ | 1.042,010 | 27.09.24 22:00:12 | +2,050 | +0,20% | 1.041,000 | 1.055,000 | 1.043,640 | 1.039,960 |
